The Drug Controller General of India on Sunday approved the Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute and indigenously developed Covaxin of Bharat Biotech, for restricted emergency use in the country, paving the way for a massive inoculation drive.
“It’s great to see India’s leadership in scientific innovation and vaccine manufacturing capability as the world works to end the COVID-19 pandemic,” Bill Gates, co-chair of the Bill & Melinda Gates Foundation, said in a tweet on Monday, tagging the Prime Minister’s Office.
Director-General of the World Health Organization Tedros Adhanom Ghebreyesus tweeted that India “continues to take decisive action & demonstrate its resolve to end #COVID19 pandemic”.
“As the world’s…
